[go: up one dir, main page]

IT8322171A0 - Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina. - Google Patents

Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.

Info

Publication number
IT8322171A0
IT8322171A0 IT8322171A IT2217183A IT8322171A0 IT 8322171 A0 IT8322171 A0 IT 8322171A0 IT 8322171 A IT8322171 A IT 8322171A IT 2217183 A IT2217183 A IT 2217183A IT 8322171 A0 IT8322171 A0 IT 8322171A0
Authority
IT
Italy
Prior art keywords
containing caffeine
inflammatory compositions
improved analgesic
analgesic
improved
Prior art date
Application number
IT8322171A
Other languages
English (en)
Other versions
IT1206501B (it
Inventor
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Original Assignee
Sunshine Abraham Laska Eugene
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunshine Abraham Laska Eugene filed Critical Sunshine Abraham Laska Eugene
Publication of IT8322171A0 publication Critical patent/IT8322171A0/it
Application granted granted Critical
Publication of IT1206501B publication Critical patent/IT1206501B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT8322171A 1982-07-22 1983-07-21 Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina. IT1206501B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
US06/474,358 US4486436A (en) 1982-07-22 1983-03-11 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Publications (2)

Publication Number Publication Date
IT8322171A0 true IT8322171A0 (it) 1983-07-21
IT1206501B IT1206501B (it) 1989-04-27

Family

ID=27017112

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8322171A IT1206501B (it) 1982-07-22 1983-07-21 Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.

Country Status (8)

Country Link
US (1) US4486436A (it)
EP (2) EP0114886B1 (it)
AT (1) ATE29965T1 (it)
AU (1) AU559218B2 (it)
CA (1) CA1228544A (it)
DE (1) DE3373866D1 (it)
IT (1) IT1206501B (it)
WO (1) WO1984000490A1 (it)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687781A (en) * 1978-03-03 1987-08-18 Endorfin, Inc. Analgesic and anti-inflammatory compositions
EP0129893B1 (en) * 1983-06-28 1991-09-04 Takeda Chemical Industries, Ltd. Ground mixture
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
WO1986003681A1 (en) * 1984-12-26 1986-07-03 Abraham Sunshine Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
CA1267092A (en) * 1985-02-25 1990-03-27 Martin D. Hynes Analgesic composition containing codeine
US4594358A (en) * 1985-02-25 1986-06-10 Eli Lilly And Company Analgesic method
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
JPH01501705A (ja) * 1986-01-30 1989-06-15 ユニバ−シテイ・オブ・ユタ 骨損失の治療
CH669523A5 (it) * 1986-06-25 1989-03-31 Mepha Ag
US5286751A (en) * 1987-12-24 1994-02-15 Analgesic Associates Sustained/enhanced antipyretic response
US4927854A (en) * 1987-12-24 1990-05-22 Analgesic Associates Sustained/enhanced analgesia
DE3800301A1 (de) * 1988-01-08 1989-07-20 Rudolf Leitz Procainhaltige salbe und ihre verwendung
US5175152A (en) * 1990-09-28 1992-12-29 Singh Nikhilesh N Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US5186222A (en) * 1991-01-07 1993-02-16 Brand Randolf W Fuel spillage control apparatus
JP2829794B2 (ja) * 1991-02-08 1998-12-02 エスエス製薬 株式会社 徐放性経口投与型プラノプロフェン製剤
JPH04346928A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 坐剤
EP0535937B2 (en) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Prolonged release microparticle preparation and production of the same
CA2149317A1 (en) * 1992-12-21 1994-07-07 Richard Wilfred D'souza Compositions and method for providing improved analgesic effect
US5760095A (en) * 1995-12-01 1998-06-02 White; Hebron B. Method and system for effecting withdrawal from caffeine dependency
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
RS49982B (sr) 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
WO2002022127A1 (en) * 2000-09-13 2002-03-21 Isis Innovation Limited Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
EP1432690A2 (en) * 2001-04-16 2004-06-30 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
US7901713B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US7901714B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
AU2002320309B2 (en) 2001-07-06 2007-07-12 Endo Pharmaceuticals, Inc. Oxymorphone controlled release formulations
KR20030048026A (ko) 2001-07-06 2003-06-18 펜웨스트 파머슈티칼즈 컴파니 옥시모르폰의 서방형 제제
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
US20040209850A1 (en) * 2003-04-15 2004-10-21 Theraquest Biosciences, Llc Methods of treating pain and compositions for use therefor
US20050065172A1 (en) * 2003-09-23 2005-03-24 Shah Indukumar G. Solid dosage form comprising caffeine
US20050067163A1 (en) * 2003-09-25 2005-03-31 George Flint R. Monobore release for tubing conveyed perforating
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
CA2618613A1 (en) 2005-08-09 2007-02-22 Metaproteomics, Llc Protein kinase modulation by hops and acacia products
JP2010526882A (ja) 2007-05-11 2010-08-05 メタプロテオミクス， エルエルシー 重金属無害化のための方法と組成物
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
US20110064813A1 (en) * 2009-09-16 2011-03-17 Charles Vaughn Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet
WO2019079729A1 (en) * 2017-10-20 2019-04-25 Purdue Pharma L.P. PHARMACEUTICAL DOSAGE FORMS
US12194046B2 (en) 2021-03-09 2025-01-14 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen

Also Published As

Publication number Publication date
DE3373866D1 (en) 1987-11-05
CA1228544A (en) 1987-10-27
WO1984000490A1 (en) 1984-02-16
AU1887783A (en) 1984-02-23
EP0114886B1 (en) 1987-09-30
EP0229022A3 (en) 1989-11-08
US4486436A (en) 1984-12-04
IT1206501B (it) 1989-04-27
ATE29965T1 (de) 1987-10-15
EP0229022A2 (en) 1987-07-15
EP0114886A1 (en) 1984-08-08
AU559218B2 (en) 1987-02-26

Similar Documents

Publication Publication Date Title
IT8322171A0 (it) Composizioni analgesiche, e antiinfiammatorie migliorate, contenenti caffeina.
NL193419B (nl) Topicaal toepasbare farmaceutische samenstellingen.
IT8220611A0 (it) Composizioni farmaceutiche topiche.
FI834235A (fi) Anordning foer placering av koniska foeremaol i en laoda.
DE3576117D1 (de) Mehrphasige pharmazeutische zusammensetzung.
IT1206502B (it) Composizioni analgesiche e antinfiammatorie migliorate, contenenti caffeina.
IT1206693B (it) Composizioni migliorate analgesiche e antiinfiammatorie contenenti ibuprofen.
FI841294A (fi) Foerfarande foer aostadkommande av foerbaettringar i boskapskoetsel.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
FI851234A0 (fi) Substituerade -aminosyror, deras framstaellning samt farmaceutiska kompositioner innehaollande dessa.
FI842596A (fi) Foerfarande foer bildande av permanentvaogor i haoret.
IT8221332A0 (it) Composizioni anticonvulsive.
NO166044C (no) Termoplast-polymerblanding.
IT8023262A0 (it) Composizioni farmaceutiche contenenti estratti di edera rampicante.
FI833831A (fi) Spridaranordning i lagerbehaollare foer jaemn fyllning av behaollaren med kornformig lagervara.
NO851146L (no) Doseringsanordning.
BE896711A (fr) Compositions pharmaceutiques anti-ulceres.
DE3381517D1 (de) Dieselkraftstoffzusammensetzung.
ATE36455T1 (de) Pharmazeutische zusammensetzungen.
FI860449A (fi) Komposition foer behandling av graesmatta.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DE3381646D1 (de) Thermochrom-zusammensetzung.
FI834627A (fi) Foerfarande foer haerdning av jaernlegeringar i vattenhaltig omgivning.
IT8123659A0 (it) Composizioni farmaceutiche contenenti amitriptilina.
FI830462A0 (fi) Mjoeldrygealkaloider, foerfarande foer deras framstaellning och dessa foereningar innehaollande farmaceutiska kompositioner

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970730